|
Market Closed -
Nasdaq
21:00:00 26/02/2026 GMT
|
5-day change | 1st Jan Change | ||
| 72.82 USD | +0.03% |
|
-.--% | +0.96% |
| 10-22 | Pharma sector doubles down on AI to slash costs, timelines | RE |
| 10-19 | Pharma sector doubles down on AI to slash costs, timelines | RE |
| Market Cap | 11.3B 10.24B 9.47B 8.54B 16.1B 1,065B 16.67B 114B 45.11B 569B 42.4B 41.5B 1,806B | P/E 2024 |
-10.1x | P/E 2025 | -14.5x |
|---|---|---|---|---|---|
| Enterprise Value | 9.65B 8.75B 8.09B 7.3B 13.75B 910B 14.24B 97.17B 38.53B 486B 36.21B 35.45B 1,543B | EV / Sales 2024 |
181x | EV / Sales 2025 | 492x |
| Free-Float |
10.55% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Avidity Biosciences, Inc.
| 1 day | +0.03% | ||
| Current year | +0.96% |
| Current year | 72 | 73.06 | |
| 1 year | 70.42 | 73.06 | |
| 3 years | 5.68 | 73.06 | |
| 5 years | 4.82 | 73.06 | |
| 10 years | 4.82 | 73.06 |
| Manager | Title | Age | Since |
|---|---|---|---|
John McKenna
PSD | President | - | 26/02/2026 |
Eduard Marti
TRE | Treasurer | - | 26/02/2026 |
Jaime S. Huertas
SEC | Corporate Secretary | - | 26/02/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Jaime S. Huertas
BRD | Director/Board Member | - | 26/02/2026 |
Eduard Marti
BRD | Director/Board Member | - | 26/02/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 27/02/26 | Issuer sale | Director | 110,073 | 0.0766% | ||
| 27/02/26 | Issuer sale | Chief Technology Officer | 547,865 | 0.3814% | ||
| 27/02/26 | Issuer sale | General Counsel | 302,054 | 0.2103% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.03% | -.--% | +2.85% | +1,068.86% | 11.3B | ||
| +1.26% | +6.61% | +40.79% | +145.27% | 1,286B | ||
| +0.79% | +3.45% | +45.84% | +92.04% | 688B | ||
| +0.20% | +1.28% | +26.97% | +114.41% | 521B | ||
| -0.44% | +3.69% | +41.45% | +70.04% | 386B | ||
| +0.55% | +0.70% | +59.02% | +45.79% | 364B | ||
| -0.12% | +0.74% | +28.39% | +60.32% | 302B | ||
| +0.37% | +0.37% | +3.33% | +38.57% | 287B | ||
| -0.30% | +1.14% | +38.29% | +70.56% | 252B | ||
| +0.08% | +0.71% | +34.44% | +123.99% | 208B | ||
| Average | +0.24% | +1.87% | +32.14% | +182.98% | 431B | |
| Weighted average by Cap. | +0.54% | +3.25% | +37.61% | +101.83% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 10.9M 9.87M 9.13M 8.24M 15.53M 1.03B 16.08M 110M 43.51M 549M 40.89M 40.03M 1.74B | 18.76M 17M 15.72M 14.18M 26.73M 1.77B 27.67M 189M 74.88M 945M 70.38M 68.89M 3B |
| Net income | -322M -292M -270M -244M -459M -30.39B -476M -3.25B -1.29B -16.23B -1.21B -1.18B -51.53B | -685M -620M -574M -518M -976M -64.55B -1.01B -6.89B -2.73B -34.48B -2.57B -2.51B -109B |
| Net Debt | -1.49B -1.35B -1.25B -1.13B -2.13B -141B -2.21B -15.05B -5.97B -75.28B -5.61B -5.49B -239B | -1.65B -1.49B -1.38B -1.25B -2.35B -155B -2.43B -16.59B -6.58B -82.99B -6.18B -6.05B -263B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- RNAM Stock
Select your edition
All financial news and data tailored to specific country editions
















